Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Elan Pharmaceuticals"
Count: 41
Selected: 0
NCT IDTitle
NCT01318421A Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis
NCT01144351A Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis
NCT00076544Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain
NCT00055484A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache
NCT00047749Prialt (Ziconotide) In Severe Chronic Pain
NCT00047580Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.
NCT00047567Open-label Adjunctive Zonisamide for Bipolar Disorder
NCT01791725A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia
NCT01766336A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease
NCT01735630Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease
NCT01674010Safety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolar I Disorder
NCT00871780A Prospective, Open-label, Non-randomized, Clinical Trial to Determine if Natalizumab (Tysabri®) Improves Ambulatory Measures in Relapsing-remitting Multiple Sclerosis (RRMS) Patients
NCT00306592Natalizumab Re-Initiation of Dosing
NCT00027300Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis
NCT00083759Natalizumab in the Treatment of Rheumatoid Arthritis in Subjects Receiving Methotrexate
NCT00831649A Phase II, Multicenter, Open-Label, Long-Term Study of the Safety, Tolerability, and Efficacy of Intravenous Natalizumab in Subjects With Rheumatoid Arthritis Who Have Previously Participated in Study ELN100226-RA201
NCT00801125Study of Tysabri (Natalizumab) in Patients Who Failed Anti-TNF-α Therapy
NCT00280956Open Label Natalizumab Safety Extension Study for Subjects With Crohn's Disease
NCT00078611A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease
NCT00055536Safety and Efficacy of Natalizumab in Combination With Remicade in the Treatment of Crohn's Disease
NCT00055367Safety, Tolerability and Effectiveness of Natalizumab in Adolescents With Active Crohn's Disease
NCT00032799Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease
NCT00032786Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease
NCT00744679A Pharmacokinetic (PK) Study of Natalizumab (Tysabri) at Steady State
NCT00559702Safety Study of Natalizumab to Treat Multiple Sclerosis (MS)
NCT01211665Corticosteroids for Immune Reconstitution Inflammatory Syndrome (IRIS)
NCT01058005Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis
NCT00472992Pregnancy Exposure Registry for Tysabri®
NCT00746941Study to Explore the Effect of Mefloquine in Participants With Progressive Multifocal Leukoencephalopathy (PML)
NCT00516893Natalizumab High Titer Immunogenicity and Safety
NCT01071083Treatment Interruption of Natalizumab
NCT00464074Evaluation of Natalizumab for thE Relief of MS Associated FatiGue
NCT00618267ATP Expression in Lymphocytes of MS Patients by Means of "ImmuKnow®" Assay.
NCT00097760Natalizumab in Combination With Glatiramer Acetate (GA) in Patients With Relapsing-Remitting Multiple Sclerosis
NCT00030966Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis
NCT00177736Pharmacodynamic Parameters of Two Different Doses of Cefepime
NCT00358202Cefepime vs. Ceftriaxone to Treat Nursing Home-Acquired Pneumonia
NCT00238641"DOES MYOBLOC™ IMPROVE FUNCTIONAL HAND USE IN YOUNG CHILDREN WITH A HYPERTONIC UPPER EXTREMITY?"
NCT01070823JC-Virus (JCV) Antibody Program
NCT01626248Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in Natalizumab Population With Active Control
NCT00035945ISIS 14803-CS2, Treatment With ISIS 14803, Administered IV in Patients With Chronic Hepatitis C Virus Infections